Key Points
-
Many important cell-cycle regulatory proteins are regulated post-translationally by ubiquitin-mediated proteolysis. These include both positive and negative regulators of the cell cycle.
-
One central role of regulated proteolysis in the context of cell-cycle control is to enforce irreversible cell-cycle phase transitions. This is often accomplished by the rapid and concerted turnover of a negative regulatory protein that impedes a cell-cycle phase transition.
-
Another important role of regulated proteolysis is to restrict the window of accumulation of a cell-cycle regulatory protein to the specific time when the function of that protein is required. Such a strategy prevents significant cell-cycle events occurring out of context.
-
There are two general classes of protein ubiquitin ligase that target cell-cycle regulatory proteins for destruction: APC/C and SCF. Whereas cell-cycle regulation of APC/C activity is intrinsic to the ligase itself, cell-cycle regulation of SCF activity is usually mediated by substrate phosphorylation.
-
SCF protein ubiquitin ligases consist of three core invariant subunits plus one of several variable specificity factors known as F-box proteins. SCFCdc4, which is conserved from yeast to humans, is the SCF protein ubiquitin ligase designated by the F-box-protein Cdc4.
-
In yeast, SCFCdc4 targets a cyclin-dependent-kinase inhibitor Sic1, thereby promoting a timely and irreversible transition from G1 to S-phase. In mammalian cells, the homologous protein ubiquitin ligase targets the positive cell-cycle-regulator cyclin E. Mutations in the human CDC4 gene are linked to cancer, presumably because they lead to deregulation of cyclin E through the cell cycle.
Abstract
Both the cell-cycle and ubiquitin-mediated-proteolysis fields have come of age over the past ten years. One byproduct of the impressive progress in these areas of investigation is the realization that they are intricately related: cell-cycle control is crucially dependent on the ubiquitin-mediated degradation of key regulatory proteins. Very recent advances have allowed an understanding of protein degradation and cell-cycle control at greatly enhanced levels of resolution. Consolidating these advances is likely to provide new insights into the regulatory biology of cell-cycle transitions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Evans, T., Rosenthal, E. T., Youngblom, J., Distel, D. & Hunt, T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33, 389–396 (1983). This was the original paper describing regulated proteolysis of cyclin as a function of cell-cycle progression. These observations were largely responsible for Tim Hunt receiving the Nobel Prize.
Hershko, A. Ubiquitin: roles in protein modification and breakdown. Cell 34, 11–12 (1983).
Schimke, R. T. & Doyle, D. Control of enzyme levels in animal tissues. Annu. Rev. Biochem. 39, 929–976 (1970).
Rossow, P. W., Riddle, V. G. & Pardee, A. B. Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth. Proc. Natl Acad. Sci. USA 76, 4446–4450 (1979).
Glotzer, M., Murray, A. W. & Kirschner, M. W. Cyclin is degraded by the ubiquitin pathway. Nature 349, 132–138 (1991). Shows that cyclins are degraded by the ubiquitin–proteasome pathway and defines the D-box degron.
Nugroho, T. T. & Mendenhall, M. D. An inhibitor of yeast cyclin-dependent protein kinase plays an important role in ensuring the genomic integrity of daughter cells. Mol. Cell. Biol. 14, 3320–3328 (1994).
Donovan, J. D., Toyn, J. H., Johnson, A. L. & Johnston, L. H. P40SDB25, a putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces cerevisiae. Genes Dev. 8, 1640–1653 (1994).
Toyn, J. H., Johnson, A. L., Donovan, J. D., Toone, W. M. & Johnston, L. H. The Swi5 transcription factor of Saccharomyces cerevisiae has a role in exit from mitosis through induction of the cdk-inhibitor Sic1 in telophase. Genetics 145, 85–96 (1997).
Schwob, E., Bohm, T., Mendenhall, M. D. & Nasmyth, K. The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae. Cell 79, 233–244 (1994). Shows how regulated proteolysis of the Cdk inhibitor Sic1 controls the G1–S transition.
Verma, R. et al. Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase. Science 278, 455–460 (1997).
Lengronne, A. & Schwob, E. The yeast CDK inhibitor Sic1 prevents genomic instability by promoting replication origin licensing in late G(1). Mol. Cell 9, 1067–1078 (2002).
Coats, S., Flanagan, W. M., Nourse, J. & Roberts, J. M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877–880 (1996).
Koff, A., Ohtsuki, M., Polyak, K., Roberts, J. M. & Massague, J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260, 536–539 (1993).
Hengst, L. & Reed, S. I. Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227, 25–41 (1998).
Harper, J. W. & Elledge, S. J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6, 56–64 (1996).
Carrano, A. C., Eytan, E., Hershko, A. & Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nature Cell Biol. 1, 193–199 (1999).
Montagnoli, A. et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13, 1181–1189 (1999).
Shirane, M. et al. Downregulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J. Biol. Chem. 274, 13886–13893 (1999).
Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H. & Zhang, H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661–664 (1999).
Erlandsson, F., Linnman, C., Ekholm, S., Bengtsson, E. & Zetterberg, A. A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells. Exp. Cell Res. 259, 86–95 (2000).
Harper, J. W. et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387–400 (1995).
Sherr, C. J. & Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149–1163 (1995).
Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).
Classon, M. & Dyson, N. p107 and p130: versatile proteins with interesting pockets. Exp. Cell Res. 264, 135–147 (2001).
Claudio, P. P., Tonini, T. & Giordano, A. The retinoblastoma family: twins or distant cousins? Genome Biol. 3, reviews 3012 (2002).
Sheaff, R. J. et al. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell 5, 403–410 (2000).
Tedesco, D., Lukas, J. & Reed, S. I. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Genes Dev. 16, 2946–2957 (2002).
Bornstein, G. et al. Role of SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 during S-phase. J. Biol. Chem. (2003).
Bloom, J. & Pagano, M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13, 41–47 (2003).
Sandhu, C. & Slingerland, J. Deregulation of the cell cycle in cancer. Cancer Detect. Prev. 24, 107–118 (2000).
Slingerland, J. & Pagano, M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 183, 10–17 (2000).
Nasmyth, K. Segregating sister genomes: the molecular biology of chromosome separation. Science 297, 559–565 (2002).
Agarwal, R. & Cohen-Fix, O. Mitotic regulation: the fine tuning of separase activity. Cell Cycle 1, 255–257 (2002).
Ciosk, R. et al. An ESP1/PDS1 complex regulates loss of sister chromatid cohesion at the metaphase to anaphase transition in yeast. Cell 93, 1067–1076 (1998).
Jensen, S., Segal, M., Clarke, D. J. & Reed, S. I. A novel role of the budding yeast separin Esp1 in anaphase spindle elongation: evidence that proper spindle association of Esp1 is regulated by Pds1. J. Cell Biol. 152, 27–40 (2001).
Yamamoto, A., Guacci, V. & Koshland, D. Pds1p is required for faithful execution of anaphase in the yeast, Saccharomyces cerevisiae. J. Cell Biol. 133, 85–97 (1996).
Jallepalli, P. V. et al. Securin is required for chromosomal stability in human cells. Cell 105, 445–457 (2001).
Irniger, S. Cyclin destruction in mitosis: a crucial task of Cdc20. FEBS Lett. 532, 7–11 (2002).
Morgan, D. O. Regulation of the APC and the exit from mitosis. Nature Cell Biol. 1, E47–E53 (1999).
Townsley, F. M. & Ruderman, J. V. Proteolytic ratchets that control progression through mitosis. Trends Cell Biol. 8, 238–244 (1998).
Schwab, M., Lutum, A. S. & Seufert, W. Yeast Hct1 is a regulator of Clb2 cyclin proteolysis. Cell 90, 683–693 (1997).
Visintin, R., Prinz, S. & Amon, A. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278, 460–463 (1997). Shows the activation of APC/C by alternative cofactors Cdc20 and Cdh1.
Lei, M. & Tye, B. K. Initiating DNA synthesis: from recruiting to activating the MCM complex. J. Cell Sci. 114, 1447–1454 (2001).
Nishitani, H. & Lygerou, Z. Control of DNA replication licensing in a cell cycle. Genes Cells 7, 523–534 (2002).
Woo, R. A., Poon, R. Y. Cylin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2, 316–324 (2003).
Keyomarsi, K. & Herliczek, T. W. The role of cyclin E in cell proliferation, development and cancer. Prog. Cell Cycle Res. 3, 171–191 (1997).
Donnellan, R. & Chetty, R. Cyclin E in human cancers. FASEB J. 13, 773–780 (1999).
Dulic, V., Lees, E. & Reed, S. I. Association of human cyclin E with a periodic G1–S phase protein kinase. Science 257, 1958–1961 (1992).
Koff, A. et al. Formation and activation of a cyclin E–cdk2 complex during the G1 phase of the human cell cycle. Science 257, 1689–1694 (1992).
Ekholm, S. V., Zickert, P., Reed, S. I. & Zetterberg, A. Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol. Cell. Biol. 21, 3256–3265 (2001).
Lew, D. J., Dulic, V. & Reed, S. I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66, 1197–1206 (1991).
Won, K. A. & Reed, S. I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15, 4182–4193 (1996).
Clurman, B. E., Sheaff, R. J., Thress, K., Groudine, M. & Roberts, J. M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10, 1979–1990 (1996).
Koepp, D. M. et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294, 173–177 (2001).
Moberg, K. H., Bell, D. W., Wahrer, D. C., Haber, D. A. & Hariharan, I. K. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413, 311–316 (2001).
Strohmaier, H. et al. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413, 316–322 (2001). References 54–56 show that cyclin E is targeted for proteolysis by an SCF ligase containing an F-box protein homologous to yeast Cdc4.
Spruck, C. et al. hCDC4 gene mutations in endometrial cancer. Cancer Res. 62, 4535–4539 (2002). Shows that Cdc4 in humans is a true tumour suppressor.
Spruck, C. H., Won, K. A. & Reed, S. I. Deregulated cyclin E induces chromosome instability. Nature 401, 297–300 (1999).
Brandeis, M. & Hunt, T. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J. 15, 5280–5289 (1996).
Zachariae, W., Schwab, M., Nasmyth, K. & Seufert, W. Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science 282, 1721–1724 (1998).
Kramer, E. R., Scheuringer, N., Podtelejnikov, A. V., Mann, M. & Peters, J. M. Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol. Biol. Cell 11, 1555–1569 (2000).
Golan, A., Yudkovsky, Y. & Hershko, A. The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk. J. Biol. Chem. 277, 15552–15557 (2002).
Rudner, A. D. & Murray, A. W. Phosphorylation by Cdc28 activates the Cdc20-dependent activity of the anaphase-promoting complex. J. Cell Biol. 149, 1377–1390 (2000).
Fang, G., Yu, H. & Kirschner, M. W. Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol. Cell 2, 163–171 (1998).
Musacchio, A. & Hardwick, K. G. The spindle checkpoint: structural insights into dynamic signalling. Nature Rev. Mol. Cell Biol. 3, 731–741 (2002).
Pfleger, C. M. & Kirschner, M. W. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev. 14, 655–665 (2000). Compares the two APC/C degron motifs, the D-box and the KEN-box.
Prinz, S., Hwang, E. S., Visintin, R. & Amon, A. The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis. Curr. Biol. 8, 750–760 (1998).
Shirayama, M., Zachariae, W., Ciosk, R. & Nasmyth, K. The Polo-like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae. EMBO J. 17, 1336–1349 (1998).
Lukas, C. et al. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 401, 815–818 (1999).
Jaspersen, S. L., Charles, J. F. & Morgan, D. O. Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14. Curr. Biol. 9, 227–236 (1999).
Burton, J. L. & Solomon, M. J. D box and KEN box motifs in budding yeast Hsl1p are required for APC-mediated degradation and direct binding to Cdc20p and Cdh1p. Genes Dev. 15, 2381–2395 (2001).
Gieffers, C., Dube, P., Harris, J. R., Stark, H. & Peters, J. M. Three-dimensional structure of the anaphase-promoting complex. Mol. Cell 7, 907–913 (2001).
Zachariae, W. et al. Mass spectrometric analysis of the anaphase-promoting complex from yeast: identification of a subunit related to cullins. Science 279, 1216–1219 (1998). Describes a mass spectrometric analysis of the yeast APC/C that defines the constituent subunits.
Skowyra, D. et al. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science 284, 662–665 (1999).
Seol, J. H. et al. Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34. Genes Dev. 13, 1614–1626 (1999).
Ohta, T., Michel, J. J., Schottelius, A. J. & Xiong, Y. ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell 3, 535–541 (1999).
Yoon, H. J. et al. Proteomics analysis identifies new components of the fission and budding yeast anaphase-promoting complexes. Curr. Biol. 12, 2048–2054 (2002).
Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263–274 (1996). Defines the F-box motif.
Cenciarelli, C. et al. Identification of a family of human F-box proteins. Curr. Biol. 9, 1177–1179 (1999).
Winston, J. T., Koepp, D. M., Zhu, C., Elledge, S. J. & Harper, J. W. A family of mammalian F-box proteins. Curr. Biol. 9, 1180–1182 (1999).
Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J. & Harper, J. W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91, 209–219 (1997).
Feldman, R. M., Correll, C. C., Kaplan, K. B. & Deshaies, R. J. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91, 221–230 (1997). References 81 and 82 show the first in vitro reconstitution of active SCF.
Verma, R., Feldman, R. M. & Deshaies, R. J. SIC1 is ubiquitinated in vitro by a pathway that requires CDC4, CDC34, and cyclin/CDK activities. Mol. Biol. Cell 8, 1427–1437 (1997).
Patton, E. E. et al. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box protein complexes that regulate cell division and methionine biosynthesis in yeast. Genes Dev. 12, 692–705 (1998).
Li, F. N. & Johnston, M. Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle. EMBO J. 16, 5629–5638 (1997).
Kaiser, P., Sia, R. A., Bardes, E. G., Lew, D. J. & Reed, S. I. Cdc34 and the F-box protein Met30 are required for degradation of the Cdk-inhibitory kinase Swe1. Genes Dev. 12, 2587–2597 (1998).
Patton, E. E. et al. SCFMet30-mediated control of the transcriptional activator Met4 is required for the G(1)–S transition. EMBO J. 19, 1613–1624 (2000).
Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799–812 (2003).
Margottin-Goguet, F. et al. Prophase destruction of Emi1 by the SCFβTrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813–826 (2003).
Schulman, B. A. et al. Insights into SCF ubiquitin ligases from the structure of the Skp1–Skp2 complex. Nature 408, 381–386 (2000).
Zheng, N. et al. Structure of the Cul1–Rbx1–Skp1– F-boxSkp2 SCF ubiquitin ligase complex. Nature 416, 703–709 (2002). References 90 and 91 describe the X-ray crystallographic structure of human SCFSkp2.
Spruck, C. et al. A CDK-independent function of mammalian Cks1: targeting of SCFSkp2 to the CDK inhibitor p27Kip1. Mol. Cell 7, 639–650 (2001).
Ganoth, D. et al. The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27. Nature Cell Biol. 3, 321–324 (2001).
Orlicky, S., Tang, X., Willems, A., Tyers, M. & Sicheri, F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 112, 243–256 (2003). Describes the X-ray crystallographic structure of Cdc4 bound to a phosphodegron peptide.
Gagne, J. M., Downes, B. P., Shiu, S. H., Durski, A. M. & Vierstra, R. D. The F-box subunit of the SCF E3 complex is encoded by a diverse superfamily of genes in Arabidopsis. Proc. Natl Acad. Sci. USA 99, 11519–11524 (2002).
Meimoun, A. et al. Degradation of the transcription factor Gcn4 requires the kinase Pho85 and the SCFCDC4 ubiquitin-ligase complex. Mol. Biol. Cell 11, 915–927 (2000).
Henchoz, S. et al. Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast. Genes Dev. 11, 3046–3060 (1997).
Oberg, C. et al. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J. Biol. Chem. 276, 35847–35853 (2001).
Gupta-Rossi, N. et al. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem. 276, 34371–34378 (2001).
Drury, L. S., Perkins, G. & Diffley, J. F. The Cdc4/34/53 pathway targets Cdc6p for proteolysis in budding yeast. EMBO J. 16, 5966–5976 (1997).
Hartwell, L. H., Culotti, J., Pringle, J. R. & Reid, B. J. Genetic control of the cell division cycle in yeast. Science 183, 46–51 (1974).
Hubbard, E. J., Wu, G., Kitajewski, J. & Greenwald, I. sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev. 11, 3182–3193 (1997).
Nash, P. et al. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414, 514–521 (2001). Describes how multiple inefficient Cdc4 degrons in Sic1 can be used to set a threshold linking phosphorylation to ubiquitylation and turnover.
Teicher, B. A., Ara, G., Herbst, R., Palombella, V. J. & Adams, J. The proteasome inhibitor PS-341 in cancer therapy. Clin. Cancer Res. 5, 2638–2645 (1999).
Zou, H., McGarry, T. J., Bernal, T. & Kirschner, M. W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285, 418–422 (1999).
Shirayama, M., Toth, A., Galova, M. & Nasmyth, K. APCCdc20 promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5. Nature 402, 203–207 (1999).
Dawson, I. A., Roth, S. & Artavanis-Tsakonas, S. The Drosophila cell cycle gene fizzy is required for normal degradation of cyclins A and B during mitosis and has homology to the CDC20 gene of Saccharomyces cerevisiae. J. Cell Biol. 129, 725–737 (1995).
Sigrist, S., Jacobs, H., Stratmann, R. & Lehner, C. F. Exit from mitosis is regulated by Drosophila fizzy and the sequential destruction of cyclins A, B and B3. EMBO J. 14, 4827–4838 (1995).
Sudakin, V. et al. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol. Biol. Cell 6, 185–197 (1995).
King, R. W. et al. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81, 279–288 (1995).
Yu, H., King, R. W., Peters, J. M. & Kirschner, M. W. Identification of a novel ubiquitin-conjugating enzyme involved in mitotic cyclin degradation. Curr. Biol. 6, 455–466 (1996).
Kramer, E. R., Gieffers, C., Holzl, G., Hengstschlager, M. & Peters, J. M. Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family. Curr. Biol. 8, 1207–1210 (1998).
Charles, J. F. et al. The Polo-related kinase Cdc5 activates and is destroyed by the mitotic cyclin destruction machinery in S. cerevisiae. Curr. Biol. 8, 497–507 (1998).
Castro, A. et al. APC/Fizzy-Related targets Aurora-A kinase for proteolysis. EMBO Rep. 3, 457–462 (2002).
Taguchi, S. et al. Degradation of human Aurora-A protein kinase is mediated by hCdh1. FEBS Lett. 519, 59–65 (2002).
Ferreira, M. F., Santocanale, C., Drury, L. S. & Diffley, J. F. Dbf4p, an essential S phase-promoting factor, is targeted for degradation by the anaphase-promoting complex. Mol. Cell Biol. 20, 242–248 (2000).
Juang, Y. L. et al. APC-mediated proteolysis of Ase1 and the morphogenesis of the mitotic spindle. Science 275, 1311–1314 (1997).
Petersen, B. O. et al. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev. 14, 2330–2343 (2000).
Bastians, H., Topper, L. M., Gorbsky, G. L. & Ruderman, J. V. Cell cycle-regulated proteolysis of mitotic target proteins. Mol. Biol. Cell 10, 3927–3941 (1999).
McGarry, T. J. & Kirschner, M. W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93, 1043–1053 (1998).
Hildebrandt, E. R. & Hoyt, M. A. Cell cycle-dependent degradation of the Saccharomyces cerevisiae spindle motor Cin8p requires APCCdh1 and a bipartite destruction sequence. Mol. Biol. Cell 12, 3402–3416 (2001).
Gordon, D. M. & Roof, D. M. Degradation of the kinesin Kip1p at anaphase onset is mediated by the anaphase-promoting complex and Cdc20p. Proc. Natl Acad. Sci. USA 98, 12515–12520 (2001).
Funabiki, H. & Murray, A. W. The Xenopus chromokinesin Xkid is essential for metaphase chromosome alignment and must be degraded to allow anaphase chromosome movement. Cell 102, 411–424 (2000).
Burton, J. L. & Solomon, M. J. Hsl1p, a Swe1p inhibitor, is degraded via the anaphase-promoting complex. Mol. Cell Biol. 20, 4614–4625 (2000).
Kominami, K. & Toda, T. Fission yeast WD-repeat protein pop1 regulates genome ploidy through ubiquitin-proteasome-mediated degradation of the CDK inhibitor Rum1 and the S-phase initiator Cdc18. Genes Dev. 11, 1548–1560 (1997).
Wolf, D. A., McKeon, F. & Jackson, P. K. F-box/WD-repeat proteins pop1p and Sud1p/Pop2p form complexes that bind and direct the proteolysis of cdc18p. Curr. Biol. 9, 373–376 (1999).
Jaquenoud, M., Gulli, M. P., Peter, K. & Peter, M. The Cdc42p effector Gic2p is targeted for ubiquitin-dependent degradation by the SCFGrr1 complex. EMBO J. 17, 5360–5373 (1998).
Bhattacharya, S. et al. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 22, 2443–2451 (2003).
Mendez, J. et al. Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Mol. Cell 9, 481–491 (2002).
Ayad, N. G. et al. Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell 113, 101–113 (2003).
Author information
Authors and Affiliations
Glossary
- CYCLIN
-
The positive regulatory subunits of cyclin-dependent kinases, usually regulated by ubiquitin-mediated proteolysis.
- UBIQUITIN
-
A 76-amino-acid polypeptide that is conjugated through an isopeptide linkage to other proteins. Most commonly, such conjugates are targeted for degradation by the proteasome.
- HETEROCHRONIC EXPRESSION
-
Expression of a protein at an inappropriate or abnormal time.
- PROTEIN-UBIQUITIN LIGASE
-
An enzyme, or enzyme complex, responsible for transferring ubiquitin to a target protein.
- SCF
-
A class of protein-ubiquitin ligase containing three core subunits (Cul1/Cdc53, Skp1 and Roc1/Rbx1) and a variable substrate-recognition subunit, which is known as an F-box protein.
- ANEUPLOIDY
-
The ploidy of a cell refers to the number of sets of chromosomes that it contains. Aneuploid karyotypes are those whose chromosome complements are not a simple multiple of the haploid set.
- CLB
-
Yeast cyclins with structural homology to metazoan cyclin B.
- CLN
-
Yeast G1 cyclins that lack strong structural homology to any metazoan cyclins.
- p130
-
A member of the pocket protein family of cell-cycle inhibitors. p130 has two modes of action: establishing transcriptional repression complexes with E2F transcription factors and inhibiting cyclin-E–Cdk2 complexes.
- PROTEASOME
-
A large intracellular protease assembly that targets ubiquitylated proteins.
- SPINDLE
-
A highly dynamic, bipolar array of microtubules that forms during mitosis or meiosis and serves to move the duplicated chromosomes apart.
- DEGRON
-
A sequence required for destabilization of a protein, usually by functioning as a recognition signal for a protein-ubiquitin ligase.
- D-BOX
-
One of two degron sequences recognized by the APC/C.
- KEN-BOX
-
One of two degron sequences recognized by the APC/C.
- CRYO-ELECTRON MICROSCOPY
-
A technique by which, using a special cryoholder, cryofixed biological samples are directly imaged in the transmission-electron microscope under low-dose conditions and at low temperature (at least −170 °C). The sample can be either a frozen layer or a suspension.
- RING-FINGER PROTEINS
-
A family of proteins structurally defined by the presence of the zinc-binding ring-finger motif. The ring consensus sequence is: CX2CX(9–39)CX(1–3)HX(2–3)C/HX2CX(4–48)CX2C. The cysteines and histidines represent metal-binding sites. The first, second, fifth and sixth of these bind one zinc ion and the third, fourth, seventh and eighth bind the second zinc ion.
- PHOSPHODEGRON
-
The phosphorylated sequence on a protein recognized by an SCF ligase.
- WD40 β-PROPELLER
-
A protein-interaction domain consisting of 40 amino-acid repeats that form a propeller-like structure, in which each repeat contributes a blade.
- DOMINANT-NEGATIVE
-
A defective protein that retains interaction capabilities and so distorts or competes with normal proteins.
Rights and permissions
About this article
Cite this article
Reed, S. Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat Rev Mol Cell Biol 4, 855–864 (2003). https://doi.org/10.1038/nrm1246
Issue Date:
DOI: https://doi.org/10.1038/nrm1246
This article is cited by
-
Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance
Journal of Molecular Medicine (2021)
-
SCFSKP2 regulates APC/CCDH1-mediated degradation of CTIP to adjust DNA-end resection in G2-phase
Cell Death & Disease (2020)
-
Protein Modifications with Ubiquitin as Response to Cerebral Ischemia-Reperfusion Injury
Translational Stroke Research (2018)
-
The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor
Nature Communications (2017)
-
Effects of Ghrelin on the Proteolytic Pathways of Alzheimer’s Disease Neuronal Cells
Molecular Neurobiology (2016)